ABIN682018
antibody from antibodies-online
Targeting: TNFRSF1A
CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN682018 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN682018, RRID:AB_11206029
- Product name
- anti-Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) (AA 22-72) antibody
- Antibody type
- Polyclonal
- Description
- Purified by Protein A.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 22-72
- Isotype
- IgG
- Vial size
- 100 μL
- Storage
- Store at -20°C
Submitted references Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.
Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
Fukui S, Nakamura H, Takahashi Y, Iwamoto N, Hasegawa H, Yanagihara K, Nakamura T, Okayama A, Kawakami A
BMC immunology 2017 Feb 3;18(1):7
BMC immunology 2017 Feb 3;18(1):7
Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
Abdel-Hamid NI, El-Azab MF, Moustafa YM
Naunyn-Schmiedeberg's archives of pharmacology 2017 Apr;390(4):379-395
Naunyn-Schmiedeberg's archives of pharmacology 2017 Apr;390(4):379-395
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC